1. Clinical Consequences of Stroke - EBRSR

ANTIPLATELET AGENTS VS. ANTICOAGULATION FOR STROKE & TIA David Lee Gordon, M.D., FAAN, FANA, FAHA Professor and Chair Department of Neurology The University of Oklahoma Health Sciences Center. OU Neurology ANTIPLATELET AGENTS VS. ... – Small infarct size ................
................